

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 5.97400328 |
| 2 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 5.97400328 |
| 3 | radial glial cell differentiation (GO:0060019) | 5.78035007 |
| 4 | regulation of cardioblast proliferation (GO:0003264) | 5.68981620 |
| 5 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 5.68981620 |
| 6 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 5.17996935 |
| 7 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 5.17996935 |
| 8 | definitive hemopoiesis (GO:0060216) | 5.04496312 |
| 9 | tolerance induction (GO:0002507) | 5.04318904 |
| 10 | regulation of cell proliferation involved in kidney development (GO:1901722) | 5.01119663 |
| 11 | positive regulation of astrocyte differentiation (GO:0048711) | 4.88776778 |
| 12 | positive regulation of mRNA catabolic process (GO:0061014) | 4.81990131 |
| 13 | response to muramyl dipeptide (GO:0032495) | 4.81207305 |
| 14 | endoderm formation (GO:0001706) | 4.44972810 |
| 15 | regulation of germinal center formation (GO:0002634) | 4.41763911 |
| 16 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.40214277 |
| 17 | regulation of timing of cell differentiation (GO:0048505) | 4.34743570 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.33639923 |
| 19 | negative regulation of cell killing (GO:0031342) | 4.33639923 |
| 20 | regulation of mRNA catabolic process (GO:0061013) | 4.31835094 |
| 21 | neuron fate determination (GO:0048664) | 4.28547794 |
| 22 | RNA destabilization (GO:0050779) | 4.19261972 |
| 23 | thrombin receptor signaling pathway (GO:0070493) | 4.05582275 |
| 24 | interleukin-1-mediated signaling pathway (GO:0070498) | 4.04987174 |
| 25 | negative regulation of interleukin-1 beta production (GO:0032691) | 4.02326929 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.97953973 |
| 27 | platelet dense granule organization (GO:0060155) | 3.96971610 |
| 28 | positive regulation of glomerulus development (GO:0090193) | 3.89654180 |
| 29 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.75250118 |
| 30 | endothelial cell chemotaxis (GO:0035767) | 3.74141448 |
| 31 | negative regulation of bone resorption (GO:0045779) | 3.74012555 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.72078630 |
| 33 | regulation of development, heterochronic (GO:0040034) | 3.69124872 |
| 34 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.63697125 |
| 35 | regulation of memory T cell differentiation (GO:0043380) | 3.62165846 |
| 36 | negative regulation of interleukin-1 production (GO:0032692) | 3.61803172 |
| 37 | cell wall macromolecule catabolic process (GO:0016998) | 3.61752569 |
| 38 | negative thymic T cell selection (GO:0045060) | 3.59831944 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 3.58635203 |
| 40 | cell proliferation involved in kidney development (GO:0072111) | 3.57137765 |
| 41 | negative T cell selection (GO:0043383) | 3.55243034 |
| 42 | mitotic cell cycle arrest (GO:0071850) | 3.54484468 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.53196087 |
| 44 | cellular response to antibiotic (GO:0071236) | 3.51495811 |
| 45 | T-helper cell differentiation (GO:0042093) | 3.45047026 |
| 46 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.45047026 |
| 47 | microglial cell activation (GO:0001774) | 3.43371156 |
| 48 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.39693987 |
| 49 | neuronal stem cell maintenance (GO:0097150) | 3.39577706 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.36588064 |
| 51 | negative regulation of protein autophosphorylation (GO:0031953) | 3.33355201 |
| 52 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.32390628 |
| 53 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.28033110 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.27758269 |
| 55 | positive regulation of p38MAPK cascade (GO:1900745) | 3.26891723 |
| 56 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.24931368 |
| 57 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.24444590 |
| 58 | neutrophil activation (GO:0042119) | 3.24080830 |
| 59 | positive regulation of mRNA 3-end processing (GO:0031442) | 3.19442869 |
| 60 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17898992 |
| 61 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.16953593 |
| 62 | cellular response to gonadotropin stimulus (GO:0071371) | 3.14330348 |
| 63 | positive regulation of Notch signaling pathway (GO:0045747) | 3.13900131 |
| 64 | regulation of cellular extravasation (GO:0002691) | 3.13471104 |
| 65 | response to laminar fluid shear stress (GO:0034616) | 3.13361185 |
| 66 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.11768431 |
| 67 | cell wall macromolecule metabolic process (GO:0044036) | 3.10439277 |
| 68 | positive thymic T cell selection (GO:0045059) | 3.08606163 |
| 69 | T cell differentiation involved in immune response (GO:0002292) | 3.07561047 |
| 70 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.07561047 |
| 71 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.07561047 |
| 72 | oligodendrocyte differentiation (GO:0048709) | 3.06909856 |
| 73 | response to follicle-stimulating hormone (GO:0032354) | 3.06729775 |
| 74 | nephron tubule morphogenesis (GO:0072078) | 3.06706826 |
| 75 | nephron epithelium morphogenesis (GO:0072088) | 3.06706826 |
| 76 | interferon-gamma production (GO:0032609) | 3.05354987 |
| 77 | regulation of glomerulus development (GO:0090192) | 3.05147675 |
| 78 | germ cell migration (GO:0008354) | 3.04890953 |
| 79 | negative regulation of glial cell proliferation (GO:0060253) | 3.03878466 |
| 80 | endocardial cushion morphogenesis (GO:0003203) | 3.03150632 |
| 81 | negative regulation of innate immune response (GO:0045824) | 3.02356666 |
| 82 | positive regulation of metanephros development (GO:0072216) | 3.02310617 |
| 83 | protein K11-linked deubiquitination (GO:0035871) | 2.98952629 |
| 84 | positive regulation of defense response to virus by host (GO:0002230) | 2.98004791 |
| 85 | regulation of monocyte differentiation (GO:0045655) | 2.95639222 |
| 86 | mast cell activation (GO:0045576) | 2.95304903 |
| 87 | response to interleukin-15 (GO:0070672) | 2.95065520 |
| 88 | lymph vessel development (GO:0001945) | 2.93188846 |
| 89 | regulation of regulatory T cell differentiation (GO:0045589) | 2.92187150 |
| 90 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.92167873 |
| 91 | negative regulation of bone remodeling (GO:0046851) | 2.91722517 |
| 92 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.91696790 |
| 93 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86980630 |
| 94 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.85436129 |
| 95 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.84753222 |
| 96 | ventricular septum development (GO:0003281) | 2.83345019 |
| 97 | dentate gyrus development (GO:0021542) | 2.81985336 |
| 98 | regulation of T-helper 1 type immune response (GO:0002825) | 2.81611412 |
| 99 | regulation of p38MAPK cascade (GO:1900744) | 2.80998324 |
| 100 | cell-cell signaling involved in cell fate commitment (GO:0045168) | 2.80239854 |
| 101 | regulation of defense response to virus by host (GO:0050691) | 2.79866054 |
| 102 | ventricular septum morphogenesis (GO:0060412) | 2.79409903 |
| 103 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.79160418 |
| 104 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.79160418 |
| 105 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.79160418 |
| 106 | negative regulation of interleukin-6 production (GO:0032715) | 2.77645970 |
| 107 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.76701790 |
| 108 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.76130440 |
| 109 | cellular response to exogenous dsRNA (GO:0071360) | 2.76115882 |
| 110 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.74917634 |
| 111 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.74341110 |
| 112 | mature B cell differentiation involved in immune response (GO:0002313) | 2.74109049 |
| 113 | neutrophil activation involved in immune response (GO:0002283) | 2.73675917 |
| 114 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.73508318 |
| 115 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.72622633 |
| 116 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.70476933 |
| 117 | positive regulation of mRNA metabolic process (GO:1903313) | 2.70370847 |
| 118 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.69148324 |
| 119 | neural crest cell development (GO:0014032) | 2.68456141 |
| 120 | granulocyte activation (GO:0036230) | 2.68064062 |
| 121 | * response to progesterone (GO:0032570) | 2.67416265 |
| 122 | alpha-beta T cell differentiation (GO:0046632) | 2.67216809 |
| 123 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.66481427 |
| 124 | positive regulation of sterol transport (GO:0032373) | 2.66185906 |
| 125 | positive regulation of cholesterol transport (GO:0032376) | 2.66185906 |
| 126 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.66156089 |
| 127 | response to nitrosative stress (GO:0051409) | 2.65865307 |
| 128 | relaxation of smooth muscle (GO:0044557) | 2.65780363 |
| 129 | phospholipid scrambling (GO:0017121) | 2.63353665 |
| 130 | * skeletal muscle cell differentiation (GO:0035914) | 2.62267898 |
| 131 | fucose catabolic process (GO:0019317) | 2.62263566 |
| 132 | L-fucose metabolic process (GO:0042354) | 2.62263566 |
| 133 | L-fucose catabolic process (GO:0042355) | 2.62263566 |
| 134 | regulation of mRNA 3-end processing (GO:0031440) | 2.61896212 |
| 135 | telencephalon development (GO:0021537) | 2.61577462 |
| 136 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.61335853 |
| 137 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.61292337 |
| 138 | dendritic cell chemotaxis (GO:0002407) | 2.61136740 |
| 139 | cranial nerve development (GO:0021545) | 2.61132582 |
| 140 | negative regulation of meiotic cell cycle (GO:0051447) | 2.60995776 |
| 141 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.60617658 |
| 142 | negative regulation of epidermis development (GO:0045683) | 2.58110730 |
| 143 | activated T cell proliferation (GO:0050798) | 2.57911659 |
| 144 | regulation of antigen processing and presentation (GO:0002577) | 2.57814277 |
| 145 | atrioventricular valve morphogenesis (GO:0003181) | 2.57116481 |
| 146 | positive T cell selection (GO:0043368) | 2.56839154 |
| 147 | gland morphogenesis (GO:0022612) | 2.55244905 |
| 148 | regulation of mast cell activation (GO:0033003) | 2.55037305 |
| 149 | mast cell degranulation (GO:0043303) | 2.54977924 |
| 150 | mast cell activation involved in immune response (GO:0002279) | 2.54977924 |
| 151 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.54106190 |
| 152 | negative regulation of smooth muscle contraction (GO:0045986) | 2.53233870 |
| 153 | positive regulation of glial cell differentiation (GO:0045687) | 2.52026229 |
| 154 | regulation of T cell mediated immunity (GO:0002709) | 2.51614059 |
| 155 | positive regulation of antigen processing and presentation (GO:0002579) | 2.50860702 |
| 156 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.50617575 |
| 157 | renal tubule morphogenesis (GO:0061333) | 2.50187530 |
| 158 | Notch receptor processing (GO:0007220) | 2.49937394 |
| 159 | lymphoid progenitor cell differentiation (GO:0002320) | 2.49922071 |
| 160 | positive regulation of mRNA processing (GO:0050685) | 2.49898015 |
| 161 | positive regulation of T cell mediated immunity (GO:0002711) | 2.48916844 |
| 162 | alpha-beta T cell activation (GO:0046631) | 2.47687315 |
| 163 | T cell selection (GO:0045058) | 2.46351653 |
| 164 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.45576529 |
| 165 | positive regulation of granulocyte differentiation (GO:0030854) | 2.44990685 |
| 166 | viral protein processing (GO:0019082) | 2.44339332 |
| 167 | inactivation of MAPK activity (GO:0000188) | 2.43850541 |
| 168 | negative regulation of tissue remodeling (GO:0034104) | 2.43785083 |
| 169 | adaptation of signaling pathway (GO:0023058) | 2.43075643 |
| 170 | labyrinthine layer blood vessel development (GO:0060716) | 2.43058870 |
| 171 | T cell differentiation (GO:0030217) | 2.42578964 |
| 172 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.42100082 |
| 173 | angiogenesis involved in wound healing (GO:0060055) | 2.41766897 |
| 174 | blood vessel maturation (GO:0001955) | 2.41678111 |
| 175 | DNA deamination (GO:0045006) | 2.41450524 |
| 176 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.41340318 |
| 177 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.41220649 |
| 178 | mesenchymal cell development (GO:0014031) | 2.40167340 |
| 179 | cell fate determination (GO:0001709) | 2.40025528 |
| 180 | cellular response to toxic substance (GO:0097237) | 2.39367898 |
| 181 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.37190101 |
| 182 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.37096283 |
| 183 | facial nerve structural organization (GO:0021612) | 2.36473185 |
| 184 | heart valve morphogenesis (GO:0003179) | 2.34902541 |
| 185 | negative regulation of gluconeogenesis (GO:0045721) | 2.34558413 |
| 186 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.34423213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.22340991 |
| 2 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.35554554 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.35552852 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.31436283 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.21666700 |
| 6 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.20939828 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.00355813 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.93460860 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.59326199 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52814947 |
| 11 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.34929953 |
| 12 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.26941117 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.20468734 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17224329 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.13526082 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.12479215 |
| 17 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.03818136 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.02639193 |
| 19 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.96406388 |
| 20 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.95102131 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 1.91592579 |
| 22 | GATA3_26560356_Chip-Seq_TH2_Human | 1.89709641 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.79286329 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73237532 |
| 25 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.69450127 |
| 26 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67677928 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.66909623 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.66649923 |
| 29 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.61889644 |
| 30 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.61662930 |
| 31 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.58393980 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.56761340 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.56541296 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55223021 |
| 35 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.52885836 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.51937157 |
| 37 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50721698 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42176632 |
| 39 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39895403 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38732685 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37952164 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.36857283 |
| 43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.36666018 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.36495893 |
| 45 | CJUN_26792858_Chip-Seq_BT549_Human | 1.34740458 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34336122 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33885908 |
| 48 | * KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.33764627 |
| 49 | * KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.33764627 |
| 50 | * KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.33764627 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32874639 |
| 52 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.32502455 |
| 53 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.31314258 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31243074 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.30604746 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27549968 |
| 57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.27524965 |
| 58 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25881017 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24974689 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24882270 |
| 61 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.23998525 |
| 62 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.23213582 |
| 63 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20471783 |
| 64 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19489427 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18895622 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18637633 |
| 67 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.17781906 |
| 68 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.17764988 |
| 69 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.17764988 |
| 70 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17396537 |
| 71 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17185547 |
| 72 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16575907 |
| 73 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16276737 |
| 74 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16227986 |
| 75 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15692532 |
| 76 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15376937 |
| 77 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.14123536 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13207435 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13117799 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12825719 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12222955 |
| 82 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11688045 |
| 83 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10888484 |
| 84 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.10829210 |
| 85 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.10410199 |
| 86 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10118982 |
| 87 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09826741 |
| 88 | MAF_26560356_Chip-Seq_TH1_Human | 1.09185600 |
| 89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08825891 |
| 90 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08704520 |
| 91 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07828071 |
| 92 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07393879 |
| 93 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05828997 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05792925 |
| 95 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05767976 |
| 96 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05296266 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04669756 |
| 98 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.04362960 |
| 99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04172121 |
| 100 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.03289705 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03258973 |
| 102 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01701193 |
| 103 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01290432 |
| 104 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.01219068 |
| 105 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00875716 |
| 106 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99451942 |
| 107 | AR_20517297_ChIP-Seq_VCAP_Human | 0.99156088 |
| 108 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98756005 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98178669 |
| 110 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98116066 |
| 111 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.97717398 |
| 112 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97681490 |
| 113 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96672529 |
| 114 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96268728 |
| 115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95942915 |
| 116 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95748342 |
| 117 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.95697390 |
| 118 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94856743 |
| 119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94812974 |
| 120 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94411924 |
| 121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94403846 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94000498 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94000498 |
| 124 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92984834 |
| 125 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.91867821 |
| 126 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91852231 |
| 127 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91655761 |
| 128 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.91497078 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91156121 |
| 130 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91029898 |
| 131 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90645157 |
| 132 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90386517 |
| 133 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90293556 |
| 134 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.90211239 |
| 135 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89190579 |
| 136 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89169953 |
| 137 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88934461 |
| 138 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88236785 |
| 139 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87005167 |
| 140 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86710546 |
| 141 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86332634 |
| 142 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86136223 |
| 143 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86136223 |
| 144 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86111872 |
| 145 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.85920594 |
| 146 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85915651 |
| 147 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85519640 |
| 148 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85209202 |
| 149 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84983365 |
| 150 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84945330 |
| 151 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84923233 |
| 152 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.84482093 |
| 153 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84396586 |
| 154 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84367123 |
| 155 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84199236 |
| 156 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83450352 |
| 157 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83120122 |
| 158 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82763987 |
| 159 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82629875 |
| 160 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82107566 |
| 161 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81455375 |
| 162 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.81362973 |
| 163 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.81362973 |
| 164 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80420295 |
| 165 | P300_19829295_ChIP-Seq_ESCs_Human | 0.80027014 |
| 166 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.79599101 |
| 167 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78275341 |
| 168 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78218049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.58810420 |
| 2 | MP0010368_abnormal_lymphatic_system | 4.20166971 |
| 3 | MP0002254_reproductive_system_inflammat | 3.90040999 |
| 4 | MP0003828_pulmonary_edema | 3.57859996 |
| 5 | MP0005646_abnormal_pituitary_gland | 3.06553115 |
| 6 | MP0005084_abnormal_gallbladder_morpholo | 2.83981884 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 2.82992951 |
| 8 | MP0002009_preneoplasia | 2.73795351 |
| 9 | MP0001851_eye_inflammation | 2.69080398 |
| 10 | MP0005671_abnormal_response_to | 2.69030811 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.28615255 |
| 12 | MP0006292_abnormal_olfactory_placode | 2.25112160 |
| 13 | MP0002928_abnormal_bile_duct | 2.22121465 |
| 14 | MP0009278_abnormal_bone_marrow | 2.00810857 |
| 15 | MP0000685_abnormal_immune_system | 1.97880953 |
| 16 | MP0003943_abnormal_hepatobiliary_system | 1.94374025 |
| 17 | MP0009379_abnormal_foot_pigmentation | 1.93392248 |
| 18 | MP0003183_abnormal_peptide_metabolism | 1.86779668 |
| 19 | MP0001346_abnormal_lacrimal_gland | 1.82540914 |
| 20 | MP0009785_altered_susceptibility_to | 1.81643008 |
| 21 | MP0002006_tumorigenesis | 1.75618797 |
| 22 | MP0001853_heart_inflammation | 1.74207504 |
| 23 | * MP0001501_abnormal_sleep_pattern | 1.70052364 |
| 24 | MP0002876_abnormal_thyroid_physiology | 1.67987405 |
| 25 | MP0003136_yellow_coat_color | 1.62884169 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.59744216 |
| 27 | * MP0005025_abnormal_response_to | 1.59566932 |
| 28 | MP0004883_abnormal_blood_vessel | 1.58799398 |
| 29 | MP0002933_joint_inflammation | 1.57005352 |
| 30 | MP0005409_darkened_coat_color | 1.56563405 |
| 31 | MP0003690_abnormal_glial_cell | 1.55285087 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.53135538 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.50029874 |
| 34 | MP0004147_increased_porphyrin_level | 1.48265690 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.47871876 |
| 36 | MP0002938_white_spotting | 1.44427605 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.43813508 |
| 38 | MP0003075_altered_response_to | 1.43716578 |
| 39 | MP0003279_aneurysm | 1.40723279 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.39488896 |
| 41 | MP0009764_decreased_sensitivity_to | 1.38571620 |
| 42 | MP0001188_hyperpigmentation | 1.33682495 |
| 43 | MP0005167_abnormal_blood-brain_barrier | 1.32551667 |
| 44 | MP0004885_abnormal_endolymph | 1.32451224 |
| 45 | MP0005670_abnormal_white_adipose | 1.31654381 |
| 46 | MP0005164_abnormal_response_to | 1.30924134 |
| 47 | MP0002405_respiratory_system_inflammati | 1.29168954 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.29081714 |
| 49 | MP0000613_abnormal_salivary_gland | 1.27315156 |
| 50 | * MP0000716_abnormal_immune_system | 1.26955886 |
| 51 | MP0000762_abnormal_tongue_morphology | 1.25825420 |
| 52 | MP0001919_abnormal_reproductive_system | 1.25420509 |
| 53 | MP0003866_abnormal_defecation | 1.25081430 |
| 54 | MP0004381_abnormal_hair_follicle | 1.22349969 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.20010383 |
| 56 | MP0004272_abnormal_basement_membrane | 1.19763499 |
| 57 | * MP0002398_abnormal_bone_marrow | 1.19431736 |
| 58 | MP0005000_abnormal_immune_tolerance | 1.19333562 |
| 59 | * MP0002419_abnormal_innate_immunity | 1.18878865 |
| 60 | MP0004947_skin_inflammation | 1.18573433 |
| 61 | * MP0000689_abnormal_spleen_morphology | 1.17912329 |
| 62 | MP0002396_abnormal_hematopoietic_system | 1.17792548 |
| 63 | MP0003011_delayed_dark_adaptation | 1.17387484 |
| 64 | MP0002132_abnormal_respiratory_system | 1.15637823 |
| 65 | MP0000467_abnormal_esophagus_morphology | 1.14134196 |
| 66 | MP0001986_abnormal_taste_sensitivity | 1.13858426 |
| 67 | MP0002060_abnormal_skin_morphology | 1.12934475 |
| 68 | * MP0002722_abnormal_immune_system | 1.11555235 |
| 69 | MP0005390_skeleton_phenotype | 1.11308360 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11274209 |
| 71 | MP0001542_abnormal_bone_strength | 1.10697277 |
| 72 | MP0000383_abnormal_hair_follicle | 1.10419316 |
| 73 | MP0008995_early_reproductive_senescence | 1.09806834 |
| 74 | MP0008007_abnormal_cellular_replicative | 1.09502715 |
| 75 | MP0003195_calcinosis | 1.08524663 |
| 76 | MP0005165_increased_susceptibility_to | 1.06133960 |
| 77 | MP0006082_CNS_inflammation | 1.06121525 |
| 78 | MP0001270_distended_abdomen | 1.04206262 |
| 79 | MP0005023_abnormal_wound_healing | 1.03977934 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 1.03471165 |
| 81 | MP0008469_abnormal_protein_level | 1.01757740 |
| 82 | MP0001835_abnormal_antigen_presentation | 1.01348003 |
| 83 | MP0001790_abnormal_immune_system | 1.01139281 |
| 84 | MP0005387_immune_system_phenotype | 1.01139281 |
| 85 | MP0000249_abnormal_blood_vessel | 1.00038413 |
| 86 | MP0001873_stomach_inflammation | 0.96596198 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.95557533 |
| 88 | MP0001502_abnormal_circadian_rhythm | 0.94818173 |
| 89 | * MP0002452_abnormal_antigen_presenting | 0.92623814 |
| 90 | * MP0002429_abnormal_blood_cell | 0.91895489 |
| 91 | MP0008872_abnormal_physiological_respon | 0.91681147 |
| 92 | MP0003763_abnormal_thymus_physiology | 0.90872536 |
| 93 | * MP0000703_abnormal_thymus_morphology | 0.90010401 |
| 94 | MP0008877_abnormal_DNA_methylation | 0.89739824 |
| 95 | * MP0002723_abnormal_immune_serum | 0.88622614 |
| 96 | MP0002295_abnormal_pulmonary_circulatio | 0.87689769 |
| 97 | MP0008004_abnormal_stomach_pH | 0.87065982 |
| 98 | MP0002166_altered_tumor_susceptibility | 0.86705009 |
| 99 | MP0003436_decreased_susceptibility_to | 0.86581158 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.85744895 |
| 101 | MP0001545_abnormal_hematopoietic_system | 0.85744895 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.85740631 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.85669833 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.85338575 |
| 105 | MP0005174_abnormal_tail_pigmentation | 0.84194077 |
| 106 | MP0005171_absent_coat_pigmentation | 0.84089266 |
| 107 | MP0001958_emphysema | 0.83718877 |
| 108 | MP0002133_abnormal_respiratory_system | 0.83624997 |
| 109 | MP0005388_respiratory_system_phenotype | 0.83624997 |
| 110 | MP0001944_abnormal_pancreas_morphology | 0.83272866 |
| 111 | MP0005464_abnormal_platelet_physiology | 0.83114653 |
| 112 | MP0002998_abnormal_bone_remodeling | 0.81720919 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.81654419 |
| 114 | MP0001800_abnormal_humoral_immune | 0.81103776 |
| 115 | * MP0005551_abnormal_eye_electrophysiolog | 0.80694674 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.80572980 |
| 117 | MP0005310_abnormal_salivary_gland | 0.79959490 |
| 118 | MP0001191_abnormal_skin_condition | 0.79639463 |
| 119 | MP0003303_peritoneal_inflammation | 0.79620609 |
| 120 | MP0005075_abnormal_melanosome_morpholog | 0.78598857 |
| 121 | MP0002098_abnormal_vibrissa_morphology | 0.78543835 |
| 122 | MP0005379_endocrine/exocrine_gland_phen | 0.78338223 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.78022587 |
| 124 | * MP0002420_abnormal_adaptive_immunity | 0.77934116 |
| 125 | MP0003252_abnormal_bile_duct | 0.77440925 |
| 126 | MP0005508_abnormal_skeleton_morphology | 0.77180468 |
| 127 | MP0010329_abnormal_lipoprotein_level | 0.76992599 |
| 128 | MP0000013_abnormal_adipose_tissue | 0.76686024 |
| 129 | MP0005389_reproductive_system_phenotype | 0.76424920 |
| 130 | MP0001968_abnormal_touch/_nociception | 0.75063658 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.74489864 |
| 132 | MP0000049_abnormal_middle_ear | 0.74068753 |
| 133 | * MP0001819_abnormal_immune_cell | 0.73951117 |
| 134 | MP0002102_abnormal_ear_morphology | 0.73838540 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.73395221 |
| 136 | MP0010678_abnormal_skin_adnexa | 0.73180685 |
| 137 | MP0001905_abnormal_dopamine_level | 0.73180493 |
| 138 | MP0010155_abnormal_intestine_physiology | 0.72656800 |
| 139 | MP0005166_decreased_susceptibility_to | 0.71251221 |
| 140 | MP0002653_abnormal_ependyma_morphology | 0.71235782 |
| 141 | MP0004484_altered_response_of | 0.67867889 |
| 142 | MP0005377_hearing/vestibular/ear_phenot | 0.67367242 |
| 143 | MP0003878_abnormal_ear_physiology | 0.67367242 |
| 144 | MP0002136_abnormal_kidney_physiology | 0.65828762 |
| 145 | MP0009763_increased_sensitivity_to | 0.65748236 |
| 146 | * MP0003795_abnormal_bone_structure | 0.64438883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.60317546 |
| 2 | Stomatitis (HP:0010280) | 4.43377598 |
| 3 | Myositis (HP:0100614) | 4.29093738 |
| 4 | Prostate neoplasm (HP:0100787) | 4.27582965 |
| 5 | Hypothermia (HP:0002045) | 4.18231383 |
| 6 | IgG deficiency (HP:0004315) | 4.05470667 |
| 7 | White forelock (HP:0002211) | 4.02360776 |
| 8 | Patchy hypopigmentation of hair (HP:0011365) | 3.85548524 |
| 9 | Optic neuritis (HP:0100653) | 3.79955021 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.79955021 |
| 11 | Stomach cancer (HP:0012126) | 3.68241134 |
| 12 | Split foot (HP:0001839) | 3.50229923 |
| 13 | Orchitis (HP:0100796) | 3.48829834 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 3.13591475 |
| 15 | Partial duplication of thumb phalanx (HP:0009944) | 3.12423132 |
| 16 | Hematochezia (HP:0002573) | 3.06966385 |
| 17 | Median cleft lip (HP:0000161) | 3.03890439 |
| 18 | Pulmonary infiltrates (HP:0002113) | 3.03357665 |
| 19 | Congenital stationary night blindness (HP:0007642) | 3.01685985 |
| 20 | Keratoconjunctivitis (HP:0001096) | 2.96238114 |
| 21 | Abnormality of eosinophils (HP:0001879) | 2.94755796 |
| 22 | True hermaphroditism (HP:0010459) | 2.91685377 |
| 23 | Submucous cleft hard palate (HP:0000176) | 2.85350323 |
| 24 | Lip pit (HP:0100267) | 2.84804821 |
| 25 | Chronic otitis media (HP:0000389) | 2.80612671 |
| 26 | Pustule (HP:0200039) | 2.79828128 |
| 27 | Recurrent fungal infections (HP:0002841) | 2.78885274 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 2.77138737 |
| 29 | Abnormality of T cells (HP:0002843) | 2.75675687 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 2.71614864 |
| 31 | Prolonged bleeding time (HP:0003010) | 2.71494471 |
| 32 | Partial duplication of the phalanx of hand (HP:0009999) | 2.70422973 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.69512271 |
| 34 | Leukocytosis (HP:0001974) | 2.63746935 |
| 35 | Stridor (HP:0010307) | 2.63633525 |
| 36 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.62246254 |
| 37 | Abolished electroretinogram (ERG) (HP:0000550) | 2.62242953 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 2.61122462 |
| 39 | Hemoptysis (HP:0002105) | 2.60326238 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.60192846 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.60192846 |
| 42 | Clumsiness (HP:0002312) | 2.59608556 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 2.56978392 |
| 44 | Congenital sensorineural hearing impairment (HP:0008527) | 2.53415255 |
| 45 | Pancreatic cysts (HP:0001737) | 2.53237362 |
| 46 | Abnormal ciliary motility (HP:0012262) | 2.52871798 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.50896567 |
| 48 | Keratoconjunctivitis sicca (HP:0001097) | 2.49969748 |
| 49 | Large for gestational age (HP:0001520) | 2.48802948 |
| 50 | Intestinal atresia (HP:0011100) | 2.46097623 |
| 51 | Attenuation of retinal blood vessels (HP:0007843) | 2.45589923 |
| 52 | Nasolacrimal duct obstruction (HP:0000579) | 2.44249945 |
| 53 | T lymphocytopenia (HP:0005403) | 2.42692104 |
| 54 | Arterial tortuosity (HP:0005116) | 2.40990721 |
| 55 | Granulocytopenia (HP:0001913) | 2.38146041 |
| 56 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.37684947 |
| 57 | Thyroiditis (HP:0100646) | 2.35812743 |
| 58 | Joint swelling (HP:0001386) | 2.35570197 |
| 59 | Conical tooth (HP:0000698) | 2.35283785 |
| 60 | Eosinophilia (HP:0001880) | 2.35261385 |
| 61 | Type II lissencephaly (HP:0007260) | 2.33029742 |
| 62 | Alveolar cell carcinoma (HP:0006519) | 2.32468021 |
| 63 | Chronic sinusitis (HP:0011109) | 2.32337460 |
| 64 | Cupped ear (HP:0000378) | 2.31564064 |
| 65 | Vascular tortuosity (HP:0004948) | 2.30947484 |
| 66 | Abnormality of the nasal septum (HP:0000419) | 2.29356606 |
| 67 | Vasculitis (HP:0002633) | 2.29346194 |
| 68 | Symptomatic seizures (HP:0011145) | 2.29206406 |
| 69 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.28020385 |
| 70 | Nephronophthisis (HP:0000090) | 2.27844421 |
| 71 | Pulmonary fibrosis (HP:0002206) | 2.25028164 |
| 72 | Gastrointestinal atresia (HP:0002589) | 2.23294425 |
| 73 | Stenosis of the external auditory canal (HP:0000402) | 2.22663044 |
| 74 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.20811148 |
| 75 | Gastrointestinal infarctions (HP:0005244) | 2.19840398 |
| 76 | Type I transferrin isoform profile (HP:0003642) | 2.19382180 |
| 77 | Pancreatic fibrosis (HP:0100732) | 2.17411882 |
| 78 | Hypoplasia of dental enamel (HP:0006297) | 2.16957258 |
| 79 | Renal cortical cysts (HP:0000803) | 2.16775690 |
| 80 | Abnormality of the renal medulla (HP:0100957) | 2.15994434 |
| 81 | Keratitis (HP:0000491) | 2.14454098 |
| 82 | Abnormal drinking behavior (HP:0030082) | 2.14272267 |
| 83 | Polydipsia (HP:0001959) | 2.14272267 |
| 84 | Mixed hearing impairment (HP:0000410) | 2.13755066 |
| 85 | Abnormality of the pleura (HP:0002103) | 2.13495469 |
| 86 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.12618575 |
| 87 | Hemiparesis (HP:0001269) | 2.12312032 |
| 88 | Metaphyseal dysplasia (HP:0100255) | 2.11350403 |
| 89 | Aplasia involving bones of the extremities (HP:0009825) | 2.11094381 |
| 90 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.11094381 |
| 91 | Aplasia of the phalanges of the hand (HP:0009802) | 2.11094381 |
| 92 | Abnormality of the prostate (HP:0008775) | 2.10866349 |
| 93 | Hypoplasia of the uterus (HP:0000013) | 2.08861858 |
| 94 | Episodic fever (HP:0001954) | 2.08392873 |
| 95 | Abnormal sex determination (HP:0012244) | 2.08370283 |
| 96 | Sex reversal (HP:0012245) | 2.08370283 |
| 97 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.06139064 |
| 98 | Agitation (HP:0000713) | 2.05991508 |
| 99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05538435 |
| 100 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.05249804 |
| 101 | Encephalitis (HP:0002383) | 2.04824223 |
| 102 | Amyloidosis (HP:0011034) | 2.03681405 |
| 103 | Pulmonary artery stenosis (HP:0004415) | 2.03052005 |
| 104 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.02595251 |
| 105 | Recurrent abscess formation (HP:0002722) | 2.01674300 |
| 106 | Spondylolisthesis (HP:0003302) | 2.01437215 |
| 107 | Generalized aminoaciduria (HP:0002909) | 2.01294767 |
| 108 | Petechiae (HP:0000967) | 2.00751620 |
| 109 | Arterial thrombosis (HP:0004420) | 2.00663935 |
| 110 | Milia (HP:0001056) | 2.00583602 |
| 111 | Facial diplegia (HP:0001349) | 2.00357177 |
| 112 | Mediastinal lymphadenopathy (HP:0100721) | 2.00056291 |
| 113 | Eczematoid dermatitis (HP:0000976) | 1.99344482 |
| 114 | Asplenia (HP:0001746) | 1.98541220 |
| 115 | Follicular hyperkeratosis (HP:0007502) | 1.98360600 |
| 116 | Onycholysis (HP:0001806) | 1.97459966 |
| 117 | Hemiplegia (HP:0002301) | 1.94807758 |
| 118 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.94665981 |
| 119 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.94665981 |
| 120 | Hypoglycemic seizures (HP:0002173) | 1.93234690 |
| 121 | Vertigo (HP:0002321) | 1.92857167 |
| 122 | Macular degeneration (HP:0000608) | 1.92091171 |
| 123 | Decreased circulating renin level (HP:0003351) | 1.91647957 |
| 124 | Abnormality of secondary sexual hair (HP:0009888) | 1.91127096 |
| 125 | Abnormality of the axillary hair (HP:0100134) | 1.91127096 |
| 126 | Xerostomia (HP:0000217) | 1.91108074 |
| 127 | Hypergonadotropic hypogonadism (HP:0000815) | 1.90369135 |
| 128 | Broad face (HP:0000283) | 1.89685548 |
| 129 | Combined immunodeficiency (HP:0005387) | 1.89422222 |
| 130 | Hypoplasia of the iris (HP:0007676) | 1.88963099 |
| 131 | Epistaxis (HP:0000421) | 1.88683872 |
| 132 | Recurrent skin infections (HP:0001581) | 1.88239774 |
| 133 | Papilledema (HP:0001085) | 1.87318662 |
| 134 | Hyperkalemia (HP:0002153) | 1.86155677 |
| 135 | Anorexia (HP:0002039) | 1.85535888 |
| 136 | Amelogenesis imperfecta (HP:0000705) | 1.85459458 |
| 137 | Urethral obstruction (HP:0000796) | 1.85067516 |
| 138 | Abnormality of the lacrimal duct (HP:0011481) | 1.84376085 |
| 139 | Hyperactive renin-angiotensin system (HP:0000841) | 1.83800429 |
| 140 | Abnormality of the nasolacrimal system (HP:0000614) | 1.83394543 |
| 141 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.83188132 |
| 142 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.82529417 |
| 143 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82221560 |
| 144 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82221560 |
| 145 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82221560 |
| 146 | Recurrent bacterial skin infections (HP:0005406) | 1.81016306 |
| 147 | Diplopia (HP:0000651) | 1.80523891 |
| 148 | Abnormality of binocular vision (HP:0011514) | 1.80523891 |
| 149 | Impaired platelet aggregation (HP:0003540) | 1.80283577 |
| 150 | Abnormal platelet function (HP:0011869) | 1.80283577 |
| 151 | Pulmonary embolism (HP:0002204) | 1.79547185 |
| 152 | Spontaneous hematomas (HP:0007420) | 1.78819617 |
| 153 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.78460063 |
| 154 | Increased IgE level (HP:0003212) | 1.78111905 |
| 155 | Interstitial pulmonary disease (HP:0006530) | 1.77935829 |
| 156 | Inflammation of the large intestine (HP:0002037) | 1.77177865 |
| 157 | Decreased central vision (HP:0007663) | 1.76752810 |
| 158 | Esophageal atresia (HP:0002032) | 1.76636963 |
| 159 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.76515283 |
| 160 | Thrombocytosis (HP:0001894) | 1.76105760 |
| 161 | Portal hypertension (HP:0001409) | 1.75253279 |
| 162 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.75122476 |
| 163 | Dysostosis multiplex (HP:0000943) | 1.73691792 |
| 164 | Meningitis (HP:0001287) | 1.73665426 |
| 165 | Medial flaring of the eyebrow (HP:0010747) | 1.73502334 |
| 166 | Abnormality of B cell number (HP:0010975) | 1.73128153 |
| 167 | Gangrene (HP:0100758) | 1.73067651 |
| 168 | Abnormality of the dental pulp (HP:0006479) | 1.73024217 |
| 169 | Progressive neurologic deterioration (HP:0002344) | 1.72982027 |
| 170 | Chest pain (HP:0100749) | 1.72139014 |
| 171 | Short tibia (HP:0005736) | 1.71393796 |
| 172 | Upper limb muscle weakness (HP:0003484) | 1.71067648 |
| 173 | Congenital, generalized hypertrichosis (HP:0004540) | 1.70851094 |
| 174 | Oligodontia (HP:0000677) | 1.70356587 |
| 175 | Autoimmune thrombocytopenia (HP:0001973) | 1.70285591 |
| 176 | Anhidrosis (HP:0000970) | 1.69876691 |
| 177 | Nephrotic syndrome (HP:0000100) | 1.69853039 |
| 178 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.69071410 |
| 179 | Cheilitis (HP:0100825) | 1.68101941 |
| 180 | Rhinitis (HP:0012384) | 1.67355602 |
| 181 | Abnormality of male internal genitalia (HP:0000022) | 1.67338661 |
| 182 | Thyroid-stimulating hormone excess (HP:0002925) | 1.66713763 |
| 183 | Distal lower limb muscle weakness (HP:0009053) | 1.66639836 |
| 184 | Laryngomalacia (HP:0001601) | 1.66453959 |
| 185 | Acne (HP:0001061) | 1.66051092 |
| 186 | Broad nasal tip (HP:0000455) | 1.65292253 |
| 187 | Abnormality of the columella (HP:0009929) | 1.61915695 |
| 188 | Ulnar claw (HP:0001178) | 1.61775188 |
| 189 | Plantar hyperkeratosis (HP:0007556) | 1.61731485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 8.60691797 |
| 2 | TAOK3 | 4.78210526 |
| 3 | TIE1 | 3.71812817 |
| 4 | GRK6 | 3.57047799 |
| 5 | TGFBR2 | 3.11370394 |
| 6 | * MAP2K2 | 2.63228794 |
| 7 | MAPKAPK5 | 2.63017783 |
| 8 | VRK1 | 2.52308160 |
| 9 | FRK | 2.39107818 |
| 10 | MAP3K2 | 2.07595838 |
| 11 | INSRR | 1.93864384 |
| 12 | EPHB1 | 1.85805423 |
| 13 | PIK3CG | 1.84204347 |
| 14 | GRK7 | 1.84163050 |
| 15 | HIPK2 | 1.80436023 |
| 16 | MAP3K14 | 1.78532338 |
| 17 | PIM2 | 1.66918073 |
| 18 | MAP3K3 | 1.66459103 |
| 19 | TLK1 | 1.60120857 |
| 20 | BMPR1B | 1.59648321 |
| 21 | MAP4K2 | 1.59275345 |
| 22 | MUSK | 1.58113605 |
| 23 | ZAP70 | 1.56484315 |
| 24 | NUAK1 | 1.51548819 |
| 25 | KDR | 1.48213502 |
| 26 | TGFBR1 | 1.44815240 |
| 27 | IRAK3 | 1.43234364 |
| 28 | KIT | 1.41345534 |
| 29 | CDK3 | 1.31689068 |
| 30 | TNK2 | 1.29796043 |
| 31 | MAP3K12 | 1.29729571 |
| 32 | SYK | 1.24682988 |
| 33 | RIPK4 | 1.23833606 |
| 34 | TSSK6 | 1.19574042 |
| 35 | PINK1 | 1.12850999 |
| 36 | MYLK | 1.11346802 |
| 37 | NLK | 1.09979314 |
| 38 | CDK8 | 1.09613312 |
| 39 | MAP2K1 | 1.02823364 |
| 40 | JAK3 | 1.01548462 |
| 41 | ADRBK2 | 1.01498260 |
| 42 | IKBKE | 1.01303323 |
| 43 | MOS | 1.00512457 |
| 44 | CASK | 0.98989787 |
| 45 | TEC | 0.97463587 |
| 46 | MAPKAPK3 | 0.91935244 |
| 47 | DYRK3 | 0.90705548 |
| 48 | EPHA3 | 0.87850172 |
| 49 | PAK2 | 0.85999800 |
| 50 | TNIK | 0.84737207 |
| 51 | PIM1 | 0.83761758 |
| 52 | IRAK4 | 0.83728826 |
| 53 | TYK2 | 0.82185825 |
| 54 | CHUK | 0.81884390 |
| 55 | HCK | 0.81418266 |
| 56 | CAMKK2 | 0.81390123 |
| 57 | GSK3A | 0.81159039 |
| 58 | PRKG2 | 0.80937176 |
| 59 | MAP3K13 | 0.80488799 |
| 60 | TRPM7 | 0.80120438 |
| 61 | DAPK2 | 0.79317237 |
| 62 | BCKDK | 0.79237822 |
| 63 | WNK4 | 0.78508814 |
| 64 | PASK | 0.78502671 |
| 65 | MAPKAPK2 | 0.78100972 |
| 66 | PIK3CA | 0.76901676 |
| 67 | TBK1 | 0.76232206 |
| 68 | PAK3 | 0.75313367 |
| 69 | PTK2B | 0.75176976 |
| 70 | NEK6 | 0.74876014 |
| 71 | BTK | 0.74121234 |
| 72 | IRAK1 | 0.72824977 |
| 73 | ERBB3 | 0.72175001 |
| 74 | PRKCQ | 0.71561972 |
| 75 | MARK3 | 0.71492683 |
| 76 | TESK2 | 0.66997138 |
| 77 | CDK19 | 0.64626758 |
| 78 | STK10 | 0.62355075 |
| 79 | GRK1 | 0.61011596 |
| 80 | RIPK1 | 0.60814093 |
| 81 | MAPK13 | 0.59484301 |
| 82 | MATK | 0.58816056 |
| 83 | RPS6KA5 | 0.58811903 |
| 84 | ABL1 | 0.58757659 |
| 85 | * MAPK3 | 0.58437831 |
| 86 | FER | 0.57939703 |
| 87 | * MAPK4 | 0.56952050 |
| 88 | BRD4 | 0.56258733 |
| 89 | FES | 0.55408244 |
| 90 | * IKBKB | 0.55382447 |
| 91 | FLT3 | 0.54726131 |
| 92 | MKNK2 | 0.53989114 |
| 93 | MAP3K1 | 0.53450543 |
| 94 | JAK2 | 0.53142000 |
| 95 | CDK9 | 0.52039544 |
| 96 | ITK | 0.51951610 |
| 97 | BMPR2 | 0.51711394 |
| 98 | PRKD2 | 0.51571483 |
| 99 | CAMK1 | 0.51359535 |
| 100 | OXSR1 | 0.51018554 |
| 101 | MST4 | 0.49456971 |
| 102 | CSF1R | 0.49100155 |
| 103 | PDK2 | 0.47278636 |
| 104 | ERBB2 | 0.46556459 |
| 105 | TXK | 0.45993373 |
| 106 | SIK2 | 0.45283847 |
| 107 | * MAPK7 | 0.44445902 |
| 108 | MAP2K3 | 0.43621284 |
| 109 | STK39 | 0.42542147 |
| 110 | CLK1 | 0.42031420 |
| 111 | PRKCE | 0.41665878 |
| 112 | GRK5 | 0.40929772 |
| 113 | MAP3K7 | 0.39097168 |
| 114 | MKNK1 | 0.38972744 |
| 115 | * RPS6KA1 | 0.38299883 |
| 116 | EIF2AK2 | 0.37938515 |
| 117 | PRKD1 | 0.37399438 |
| 118 | MAP4K1 | 0.35691267 |
| 119 | FGFR3 | 0.35554231 |
| 120 | MAP2K6 | 0.35499797 |
| 121 | MAPK12 | 0.35354694 |
| 122 | PHKG2 | 0.35254788 |
| 123 | PHKG1 | 0.35254788 |
| 124 | MARK2 | 0.35098054 |
| 125 | PDK1 | 0.34416642 |
| 126 | ADRBK1 | 0.33661492 |
| 127 | JAK1 | 0.33490335 |
| 128 | CSK | 0.33417026 |
| 129 | IGF1R | 0.33066370 |
| 130 | * MAPK1 | 0.32856230 |
| 131 | RPS6KB2 | 0.32427391 |
| 132 | ZAK | 0.32235833 |
| 133 | BLK | 0.32032203 |
| 134 | CAMK4 | 0.31798111 |
| 135 | LYN | 0.31571518 |
| 136 | SGK494 | 0.31496074 |
| 137 | SGK223 | 0.31496074 |
| 138 | LCK | 0.30515262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.59022864 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.60017812 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.24533879 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.23823088 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.20100956 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.17616961 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05850679 |
| 8 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.02262624 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.93972939 |
| 10 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81862037 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81446376 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.74320604 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.71714631 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.66501586 |
| 15 | Cocaine addiction_Homo sapiens_hsa05030 | 1.64663290 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.60642923 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58821129 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53803290 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.53407738 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52575077 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.39683433 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.38643712 |
| 23 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.35779853 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35670730 |
| 25 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.35488174 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.32454924 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32091806 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.30023860 |
| 29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29536937 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25413982 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.24883784 |
| 32 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23589479 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23259823 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.22151085 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20537011 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20117914 |
| 37 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.17172373 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.16059397 |
| 39 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.16010111 |
| 40 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14576298 |
| 41 | * Leishmaniasis_Homo sapiens_hsa05140 | 1.13621373 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12657115 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.11402121 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07785986 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06437431 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05567031 |
| 47 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.05535181 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02660754 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.02419929 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02067077 |
| 51 | * Pertussis_Homo sapiens_hsa05133 | 0.99151472 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98653380 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98244800 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98217022 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95832199 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93769698 |
| 57 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.93541592 |
| 58 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91562793 |
| 59 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.91062289 |
| 60 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.90995880 |
| 61 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90683691 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.89756397 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86806671 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86034229 |
| 65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85947047 |
| 66 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.83623459 |
| 67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81882449 |
| 68 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.81210074 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.80353949 |
| 70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79070754 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 0.78941397 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78609977 |
| 73 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76647275 |
| 74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.76334883 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76309122 |
| 76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75606327 |
| 77 | Focal adhesion_Homo sapiens_hsa04510 | 0.75013158 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73324219 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72013429 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71768293 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.71565207 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68360925 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.67978765 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67642473 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67422593 |
| 86 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67407695 |
| 87 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.67367435 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.67081681 |
| 89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66808160 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.66776364 |
| 91 | Taste transduction_Homo sapiens_hsa04742 | 0.66491593 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66468066 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.66102143 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.65573487 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.65228232 |
| 96 | * Apoptosis_Homo sapiens_hsa04210 | 0.63989977 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63848508 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63824829 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.63694301 |
| 100 | * Hepatitis B_Homo sapiens_hsa05161 | 0.63278703 |
| 101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62408811 |
| 102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62181172 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61779219 |
| 104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61418058 |
| 105 | Legionellosis_Homo sapiens_hsa05134 | 0.59983512 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.59474595 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59468980 |
| 108 | * Amphetamine addiction_Homo sapiens_hsa05031 | 0.59305711 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58950079 |
| 110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58843498 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58162777 |
| 112 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.57679534 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57456712 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57309364 |
| 115 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56518872 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.55980861 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55533477 |
| 118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54943345 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54573126 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54484588 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54083056 |
| 122 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53753958 |
| 123 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53734838 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53686158 |
| 125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.53039106 |
| 126 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52777395 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51780809 |
| 128 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51260060 |
| 129 | Renin secretion_Homo sapiens_hsa04924 | 0.49987326 |
| 130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49500614 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48829299 |
| 132 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45510909 |
| 133 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42166648 |
| 134 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40005956 |
| 135 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39423162 |
| 136 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37128840 |
| 137 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36639202 |

